Don't quote me on this, but I'm sure that I've either heard or read they own or have interests in more than 10.
ALT can't speed up the regulatory approval, but once done you'd expect TAD to roll the product out to all their hospitals yes. I imagine they are doing their internal trials concurrently while the regulatory approval is taking place to save time and expedite the roll out.
I'm keen for an update on Brazil so may give them a call this week and inquire.
ALT Price at posting:
2.1¢ Sentiment: Buy Disclosure: Held
